Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stock Plans and Stock-Based Compensation (Tables)

Stock Plans and Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2014

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Assumptions used to calculate fair value for stock based awards

The following assumptions were used:

	2014	2013	2012
Exercise price	n/a	$1.71$9.21	$4.75$7.84
Expected stock price volatility	n/a	81.3%112.7%	87.3%114.3%
Risk free rate of interest	n/a	1.01%3.04%	0.16%2.23%
Expected life of options	n/a	6 years10 years	2 years10 years

Components of Stock-Based Compensation Expenses

The following table summarizes the stock-based compensation expense from stock option, employee stock purchase programs and restricted Common Stock awards and warrants for the years ended December 31, 2014, 2013 and 2012

	2014		2013		2012
($ in thousands)
Employee awards	$	5,492	$	4,867	$	2,408
Non-employee awards		54		897		664
Non-employee warrants				138		566
Total compensation expense	$	5,546	$	5,902	$	3,638

Summary of Stock Option Activity

The following table summarizes stock option activity:

	Outstanding Options						Weighted
	Number of Shares		Weighted Average Exercise Price		Total Weighted Average Intrinsic Value		Average Remaining Contractual Life (in years)
($ in thousands except per share amounts)
Outstanding at December 31, 2013		3,117,777	$	4.31	$			8.36
Options granted			$
Options exercised		(323,412)	$	1.84		193
Options cancelled/forfeited		(630,000)	$	4.28
Outstanding at December 31, 2014		2,164,365	$	4.69	$			7.38
Options vested and expected to vest		2,164,365	$	4.69	$			7.38
Options vested and exercisable		1,731,032	$	4.33	$			7.18

Nonvested Restricted Stock Shares Activity

The following table summarizes restricted stock activity:

	Restricted Stock
			Weighted
			Average Grant
	Number of		Date
	Shares		Fair Value
Unvested balance at December 31, 2013		3,958,692	$	1.93
Restricted stock granted		4,343,692		2.69
Restricted stock vested		-		-
Restricted stock forfeited		(15,000)		2.69
Unvested balance at December 31, 2014		8,287,384	$	2.33